HOVON HO168 NHL
Gepland
Main info
- Identificatie:
- HO168-DLBCL
- Sponsor:
- HOVON
- Working group party:
- Lymphoma
- Stadium:
- 1st lijn
- Echelon:
- Level D
- Included patients:
-
0(of 276)
- Active sites:
-
0(of 60)55 sites are pending
- Title:
Epcoritamab in Addition to R-Mini-CHOP Compared to R-Mini-CHOP in Elderly
Frail or Unfit Patients with Diffuse Large B-cell Lymphoma
Timeline
Scheduled
Actual
2022
21 jun.
Opportunity
2024
04 mrt.
Development
2026
31 mrt.
Submission in Progress
2026
11 mei
Submission in Progress
2026
07 sep.
EC Approval
2026
30 sep.
Activated
2026
15 okt.
First Site
2026
30 okt.
FPI
2029
28 sep.
ClosedForInclusionScheduledStart
2031
19 dec.
Closeout in Progress
2032
16 feb.
Endpoint Analysis
2032
30 apr.
Archived
Details
- Phase:
- Prospective randomized Phase II study
- Monitoring Type:
- HOVON Monitoring Visit
- Objectives:
Participating Sites
Site
55 results
Order by
Accrual rate
Activation date
BE-Sint Niklaas-VITAZ
IE-Dublin 8-STJAMES
IE-Dublin 7-MATER
IE-Limerick-UHL
ES-Barcelona-SANTPAU
SE-Stockholm-KAROLINSKASOLNA
ES-Madrid-OCTUBRE
ES-Salamanca-CASTILLAYLEON
ES-Barcelona-ICODURANREYNALS
FI-Tampere-TAYS
FI-Oulu-OYS
FI-Helsinki-HUS
IE-Galway-UHGALWAY
IE-Dublin 9-BEAUMONT
CZ-Praag 2-VFN
HR-Zagreb-UHCZ
HR-Zagreb-DUBRAVA
HR-Zagreb-SOC
HR-Zagreb-MERKUR
HR-Split-KBC
IE-Waterford City-WATERFORD
BE-Brasschaat-KLINA
CZ-Praag 10-FNKV
PT-Lisboa-DESANTAMARIA
PT-Coimbra-COIMBRAUH
PT-Lisboa-IPOLISBOA
CZ-Plzen-FNPLZEN
CZ-Hradec Kralove-FNHK
NL-Emmen-SCHEPER
DK-Aarhus N-AUH
NO-Bergen-HELSEBERGEN
NL-Dordrecht-ASZ
NL-Hoofddorp-SPAARNEGASTHUIS
NL-Deventer-DZ
BE-Leuven-UZLEUVEN
NL-Zwolle-ISALA
NL-Nieuwegein-ANTONIUS
NL-Leeuwarden-MCL
NL-Groningen-UMCG
NL-Den Bosch-JBZ
DK-Copenhagen-RIGSHOSPITALET
DK-Odense-OUH
NL-Almere-FLEVOZIEKENHUIS
CZ-Ostrava-Poruba-FNO
CZ-Olomouc-FNOL
BE-Gent-UZGENT
BE-Brugge-AZBRUGGE
SE-Lund-SUH
SE-Goteborg-SAHLGRENSKA
NO-Trondheim-STOLAV
NO-Oslo-OSLOUH
NL-Uden-BERNHOVEN
NL-Rotterdam-SFG
NL-Arnhem-RIJNSTATE
NL-Delft-RDGG
= Active hospitals 
= Inactive hospitals